4//SEC Filing
Shiferman Gregory L. 4
Accession 0001562180-24-007490
CIK 0001597553other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 4:24 PM ET
Size
9.6 KB
Accession
0001562180-24-007490
Insider Transaction Report
Form 4
Shiferman Gregory L.
See Remarks
Transactions
- Award
Stock Option (Right to buy)
2024-11-01+10,000→ 10,000 totalExercise: $6.05Exp: 2034-10-31→ Common Stock (10,000 underlying) - Award
Common Stock
2024-11-01+5,000→ 19,967 total
Footnotes (2)
- [F1]Consists of shares of Common Stock issuable under 5,000 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Sage Therapeutics, Inc. 2024 Equity Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on November 1, 2025, subject to the Reporting Person's continued service.
- [F2]The option was granted on November 1, 2024, pursuant to the Plan. The shares underlying the option vest over four years, with 25% of the shares vesting on November 1, 2025, and the remainder vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0002041689
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 4:24 PM ET
- Size
- 9.6 KB